Morgan Stanley Portfolio holdings
Morgan Stanley is a financial services company with divisions for institutional services, wealth management and investment management. Its institutional arm advises large institutions on strategy and raising capital, its wealth arm serves individuals and family offices and runs the E-Trade self-directed investing service, and its investment arm offers hedge fund, real estate and infrastructure strategies as well as private equity and private credit. It was founded in 1935 by Harold Stanley and Henry Sturgis Morgan, who was J.P. Morgan's grandson, both leaving J.P. Morgan & Co., after the Glass-Steagall Act forced commercial and investment banking apart. In 1997 it merged with Dean Witter Discover, the financial services business Sears had spun off, and it went back to the Morgan Stanley name in 2001. In 2009 its wealth business was merged with Citigroup's Smith Barney, and in 2012 Morgan Stanley bought a larger share of that venture from Citigroup. Morgan Stanley later bought E-Trade in 2020 and Eaton Vance in 2021.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2426
Vistance Networks Inc
VISN
$1.51B
| $41.3M | ﹤0.01% |
3,228,528
-754,662
| -19% | -$10.7M |
2013 Q4
50 quarters
|
|
2427
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.6B
| $41.2M | ﹤0.01% |
1,669,051
-141,651
| -8% | -$3.5M |
2015 Q1
45 quarters
|
|
2428
Mirum Pharmaceuticals
MIRM
$5.52B
| $41.1M | ﹤0.01% |
351,404
-173,162
| -33% | -$17.4M |
2019 Q3
27 quarters
|
|
2429
News Corp Class B
NWS
$17.1B
| $41.1M | ﹤0.01% |
1,465,809
-18,686
| -1% | -$555K |
2013 Q3
51 quarters
|
|
2430
Invesco DB Agriculture Fund
DBA
$1.16B
| $41.1M | ﹤0.01% |
1,540,020
+363,693
| +31% | +$9.9M |
2013 Q2
52 quarters
|
|
2431
VanEck Agribusiness ETF
MOO
$1.11B
| $41.1M | ﹤0.01% |
518,429
+163,711
| +46% | +$13.3M |
2013 Q2
52 quarters
|
|
2432
Davis Select Financial ETF
DFNL
$453M
| $41.1M | ﹤0.01% |
831,587
-20,112
| -2% | -$945K |
2017 Q3
35 quarters
|
|
2433
abrdn Global Infrastructure Income Fund
ASGI
$864M
| $41M | ﹤0.01% |
1,764,869
-236,410
| -12% | -$5.54M |
2021 Q1
21 quarters
|
|
2434
First Trust Growth Strength ETF
FTGS
$1.27B
| $41M | ﹤0.01% |
1,108,922
+81,959
| +8% | +$2.98M |
2024 Q3
7 quarters
|
|
2435
Lineage Inc
LINE
$8.2B
| $41M | ﹤0.01% |
947,862
+260
| +0% | +$10.2K |
2024 Q3
7 quarters
|
|
2436
CorVel
CRVL
$4.15B
| $41M | ﹤0.01% |
655,700
-39,206
| -6% | -$2.29M |
2013 Q2
52 quarters
|
|
2437
Park Hotels & Resorts
PK
$3.34B
| $41M | ﹤0.01% |
2,875,320
-142,577
| -5% | -$1.74M |
2017 Q1
37 quarters
|
|
2438
Main Street Capital
MAIN
$5.17B
| $40.8M | ﹤0.01% |
786,284
-68,301
| -8% | -$3.6M |
2013 Q2
52 quarters
|
|
2439
Supernus Pharmaceuticals
SUPN
$2.44B
| $40.8M | ﹤0.01% |
876,841
-37,052
| -4% | -$1.78M |
2013 Q2
52 quarters
|
|
2440
Waystar Holding Corp
WAY
$5.37B
| $40.8M | ﹤0.01% |
1,986,453
+1,027,286
| +107% | +$21.6M |
2024 Q2
8 quarters
|
|
2441
Invesco Solar ETF
TAN
$843M
| $40.7M | ﹤0.01% |
688,518
+246,235
| +56% | +$15M |
2013 Q2
52 quarters
|
|
2442
State Street SPDR S&P International Dividend ETF
DWX
$520M
| $40.6M | ﹤0.01% |
884,037
+31,804
| +4% | +$1.48M |
2013 Q2
52 quarters
|
|
2443
Southwest Gas
SWX
$6.74B
| $40.6M | ﹤0.01% |
457,850
-212,493
| -32% | -$19M |
2013 Q2
52 quarters
|
|
2444
Rush Enterprises Class A
RUSHA
$5.02B
| $40.6M | ﹤0.01% |
833,420
+31,988
| +4% | +$1.5M |
2013 Q3
51 quarters
|
|
2445
First Trust Enhanced Equity Income Fund
FFA
$440M
| $40.5M | ﹤0.01% |
1,809,892
+27,041
| +2% | +$600K |
2013 Q2
52 quarters
|
|
2446
Alignment Healthcare
ALHC
$1.51B
| $40.5M | ﹤0.01% |
1,698,938
+172,099
| +11% | +$3.3M |
2021 Q1
21 quarters
|
|
2447
Par Pacific Holdings
PARR
$3.82B
| $40.4M | ﹤0.01% |
720,138
-193,160
| -21% | -$11.5M |
2014 Q3
47 quarters
|
|
2448
State Street SPDR Dow Jones REIT ETF
RWR
$1.82B
| $40.3M | ﹤0.01% |
357,038
-16,770
| -4% | -$1.84M |
2013 Q2
52 quarters
|
|
2449
Legend Biotech
LEGN
$4.21B
| $40.3M | ﹤0.01% |
1,394,531
+791,284
| +131% | +$21.3M |
2020 Q2
24 quarters
|
|
2450
iShares MSCI Global Gold Miners ETF
RING
$2.04B
| $40.2M | ﹤0.01% |
622,009
+24,849
| +4% | +$1.9M |
2013 Q2
52 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 302 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 302 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.